Cellular therapies have changed #immunooncology (IO) dramatically but their clinical and technical challenges in remain. Marco Donia (DK) elegantly summarized the developments and puts cutting-edge strategies on show at #ESMOimmuno25 in London. Careful patient selection is a decisive step to identify the patients who can benefit. This leads to impressive clinical results. So the role of systematic evaluation of IO-Biomarkers is paramount. #immunotherapy #immunology #Science #health

Great pleasure to be part of the European Society for Medical Oncology Immunooncology meeting in London #esmoimmuno25 as a scientific committee member, chair and invited speaker. The first day already kicks off with brilliant talks on tertiary lymphoid structures and triads as niches for anti-tumoral activiation in the tissue. A packed auditorium and exciting discussions with Samra Turajlić taking the stage right now. #tls #immunobiology #oncology #science #health https://www.esmo.org/